These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 18976206)

  • 21. Severe Buruli Ulcer Treated with Minimal Surgical Excision after Prior Biopsy Mapping.
    Kabuto M; Fujimoto N; Takahashi T; Nakanishi G; Nakanishi T; Tanaka T
    Acta Derm Venereol; 2016 Nov; 96(7):982-984. PubMed ID: 27026220
    [No Abstract]   [Full Text] [Related]  

  • 22. Buruli Ulcer: Review of a Neglected Skin Mycobacterial Disease.
    Guarner J
    J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29343539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A Papua New Guinean with three foot ulcers].
    Coenders A; Verregghen M; Baerends EP
    Ned Tijdschr Geneeskd; 2018; 162():D2295. PubMed ID: 29372678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Painful Buruli ulcer in a Malian visitor to France.
    Ezzedine K; Pistone T; Guir V; Malvy D
    Acta Derm Venereol; 2010 Jul; 90(4):424. PubMed ID: 20574617
    [No Abstract]   [Full Text] [Related]  

  • 25. Successful outcomes with oral fluoroquinolones combined with rifampicin in the treatment of Mycobacterium ulcerans: an observational cohort study.
    O'Brien DP; McDonald A; Callan P; Robson M; Friedman ND; Hughes A; Holten I; Walton A; Athan E
    PLoS Negl Trop Dis; 2012 Jan; 6(1):e1473. PubMed ID: 22272368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New foci of Buruli ulcer, Angola and Democratic Republic of Congo.
    Kibadi K; Panda M; Tamfum JJ; Fraga AG; Longatto Filho A; Anyo G; Pedrosa J; Nakazawa Y; Suykerbuyk P; Meyers WM; Portaels F
    Emerg Infect Dis; 2008 Nov; 14(11):1790-2. PubMed ID: 18976574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treating Mycobacterium ulcerans disease (Buruli ulcer): from surgery to antibiotics, is the pill mightier than the knife?
    Converse PJ; Nuermberger EL; Almeida DV; Grosset JH
    Future Microbiol; 2011 Oct; 6(10):1185-98. PubMed ID: 22004037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting the Mycobacterium ulcerans cytochrome bc
    Scherr N; Bieri R; Thomas SS; Chauffour A; Kalia NP; Schneide P; Ruf MT; Lamelas A; Manimekalai MSS; Grüber G; Ishii N; Suzuki K; Tanner M; Moraski GC; Miller MJ; Witschel M; Jarlier V; Pluschke G; Pethe K
    Nat Commun; 2018 Dec; 9(1):5370. PubMed ID: 30560872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stable and Local Reservoirs of Mycobacterium ulcerans Inferred from the Nonrandom Distribution of Bacterial Genotypes, Benin.
    Coudereau C; Besnard A; Robbe-Saule M; Bris C; Kempf M; Johnson RC; Brou TY; Gnimavo R; Eyangoh S; Khater F; Marion E
    Emerg Infect Dis; 2020 Mar; 26(3):491-503. PubMed ID: 32091371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Buruli ulcer. A disabling infection.
    Prescrire Int; 2010 Nov; 19(110):261-2. PubMed ID: 21284361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Buruli ulcer disease in Republic of the Congo.
    Marion E; Obvala D; Babonneau J; Kempf M; Asiedu KB; Marsollier L
    Emerg Infect Dis; 2014 Jun; 20(6):1070-2. PubMed ID: 24857328
    [No Abstract]   [Full Text] [Related]  

  • 32. Mycobacterium ulcerans infection (Buruli ulcer): first reported case in a traveler.
    Semret M; Koromihis G; MacLean JD; Libman M; Ward BJ
    Am J Trop Med Hyg; 1999 Nov; 61(5):689-93. PubMed ID: 10586895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of 8 weeks standard treatment (rifampicin plus clarithromycin) vs. 4 weeks standard plus amoxicillin/clavulanate treatment [RC8 vs. RCA4] to shorten Buruli ulcer disease therapy (the BLMs4BU trial): study protocol for a randomized controlled multi-centre trial in Benin.
    Johnson RC; Sáez-López E; Anagonou ES; Kpoton GG; Ayelo AG; Gnimavo RS; Mignanwande FZ; Houezo JG; Sopoh GE; Addo J; Orford L; Vlasakakis G; Biswas N; Calderon F; Della Pasqua O; Gine-March A; Herrador Z; Mendoza-Losana A; Díez G; Cruz I; Ramón-García S
    Trials; 2022 Jul; 23(1):559. PubMed ID: 35804454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Promising clinical efficacy of streptomycin-rifampin combination for treatment of buruli ulcer (Mycobacterium ulcerans disease).
    Chauty A; Ardant MF; Adeye A; Euverte H; Guédénon A; Johnson C; Aubry J; Nuermberger E; Grosset J
    Antimicrob Agents Chemother; 2007 Nov; 51(11):4029-35. PubMed ID: 17526760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Buruli ulcer in traveler from Suriname, South America, to the Netherlands.
    Faber WR; de Jong B; de Vries HJ; Zeegelaar JE; Portaels F
    Emerg Infect Dis; 2015 Mar; 21(3):497-9. PubMed ID: 25695367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-Dose Rifamycins Enable Shorter Oral Treatment in a Murine Model of Mycobacterium ulcerans Disease.
    Omansen TF; Almeida D; Converse PJ; Li SY; Lee J; Stienstra Y; van der Werf T; Grosset JH; Nuermberger EL
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30455239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Orally administered combined regimens for treatment of Mycobacterium ulcerans infection in mice.
    Ji B; Chauffour A; Robert J; Lefrançois S; Jarlier V
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3737-9. PubMed ID: 17664316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial.
    Phillips RO; Robert J; Abass KM; Thompson W; Sarfo FS; Wilson T; Sarpong G; Gateau T; Chauty A; Omollo R; Ochieng Otieno M; Egondi TW; Ampadu EO; Agossadou D; Marion E; Ganlonon L; Wansbrough-Jones M; Grosset J; Macdonald JM; Treadwell T; Saunderson P; Paintsil A; Lehman L; Frimpong M; Sarpong NF; Saizonou R; Tiendrebeogo A; Ohene SA; Stienstra Y; Asiedu KB; van der Werf TS;
    Lancet; 2020 Apr; 395(10232):1259-1267. PubMed ID: 32171422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increasing Experience with Primary Oral Medical Therapy for Mycobacterium ulcerans Disease in an Australian Cohort.
    Friedman ND; Athan E; Walton AL; O'Brien DP
    Antimicrob Agents Chemother; 2016 May; 60(5):2692-5. PubMed ID: 26883709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. All-oral antibiotic treatment for buruli ulcer: a report of four patients.
    Gordon CL; Buntine JA; Hayman JA; Lavender CJ; Fyfe JA; Hosking P; Starr M; Johnson PD
    PLoS Negl Trop Dis; 2010 Nov; 4(11):e770. PubMed ID: 21152060
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.